- Home
- MNPR vs CCSI Comparison
MNPR vs CCSI Comparison
Compare MNPR & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- CCSI
- Stock Information
- Founded
- MNPR 2014
- CCSI 2021
- Country
- MNPR United States
- CCSI United States
- Employees
- MNPR N/A
- CCSI N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- CCSI Retail: Computer Software & Peripheral Equipment
- Sector
- MNPR Health Care
- CCSI Technology
- Exchange
- MNPR Nasdaq
- CCSI Nasdaq
- Market Cap
- MNPR 531.6M
- CCSI 549.8M
- IPO Year
- MNPR 2019
- CCSI N/A
- Fundamental
- Price
- MNPR $92.78
- CCSI $21.06
- Analyst Decision
- MNPR Strong Buy
- CCSI Hold
- Analyst Count
- MNPR 13
- CCSI 3
- Target Price
- MNPR $97.83
- CCSI $29.00
- AVG Volume (30 Days)
- MNPR 161.9K
- CCSI 195.2K
- Earning Date
- MNPR 11-13-2025
- CCSI 11-05-2025
- Dividend Yield
- MNPR N/A
- CCSI N/A
- EPS Growth
- MNPR N/A
- CCSI N/A
- EPS
- MNPR N/A
- CCSI 4.22
- Revenue
- MNPR N/A
- CCSI $349,609,000.00
- Revenue This Year
- MNPR N/A
- CCSI $1.55
- Revenue Next Year
- MNPR N/A
- CCSI $1.10
- P/E Ratio
- MNPR N/A
- CCSI $5.00
- Revenue Growth
- MNPR N/A
- CCSI N/A
- 52 Week Low
- MNPR $18.67
- CCSI $17.84
- 52 Week High
- MNPR $105.00
- CCSI $32.10
- Technical
- Relative Strength Index (RSI)
- MNPR 64.12
- CCSI 31.23
- Support Level
- MNPR $74.58
- CCSI $20.20
- Resistance Level
- MNPR $84.06
- CCSI $22.01
- Average True Range (ATR)
- MNPR 6.71
- CCSI 1.32
- MACD
- MNPR 0.32
- CCSI -0.54
- Stochastic Oscillator
- MNPR 95.22
- CCSI 7.55
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.